Skip to: Content
Skip to: Site Navigation
Skip to: Search

December 4, 2008 3:54:52 PM CST

Learn about Newser Points »

« Back to the grid | Next story »

Drug Therapy Cuts Risk of Breast Cancer Relapse

Posted Mar 11, 08 7:16 AM CDT in Science & Health 

(Newser) – New research shows that women can cut the risk of breast cancer recurring years later by taking certain drugs, the Washington Post reports. Studies show that the drugs, known as aromatase inhibitors, sharply reduced the risk of cancer's return after women had finished their regimen of the widely used tamoxifen. The findings could dramatically change the treatments breast cancer survivors are given.

Tamoxifen, an estrogen blocker, reduces the risk of breast cancer returning, but it loses effectiveness and raises other health risks after five years. "What is important for doctors and patients to recognize unfortunately is that the risk of recurrence of this type of breast cancer does not end at five years," a researcher told Reuters. Aromatase inhibitors cut the cancer risk even in women who had ceased taking tamoxifen 7 years earlier.

Sources Washington Post, Reuters

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon

Related Newser Stories

  • Weight Can Increase Risk of Breast Cancer

    Oct 8, 08 3:44 PM CDT
    Weight Can Increase Risk of Breast Cancer There may be a direct connection between weight and breast cancer in women, MSNBC reports. Overweight women “have more exposure to estrogen,” one doctor said, "which we think increases their risk of several different cancers.” Breast cancer patients across the country are now coupling their therapy with weight loss programs, but the side effects of cancer treatment can make it even harder to shed the pounds. More »

  • Gene Variants Increase Breast Cancer Risk

    Apr 28, 08 10:42 AM CDT
    Gene Variants Increase Breast Cancer Risk Scientists have identified versions of a gene that confer a 50% greater chance of developing estrogen-responsive tumors, Bloomberg reports. The study, published in Nature Genetics, found two common gene variants on chromosome 5 that correlated with higher incidences of the types of cancer that respond to estrogen levels. Genetic testing could indicate which women might benefit most from hormone-blocking therapy. More »

  • Cancer Still Winning War ...on Cancer

    Dec 2, 07 5:35 PM CST
    Cancer Still Winning War ...on Cancer Nixon declared war on cancer in '71, but $69 billion in funding and claims of near victory are yet to slow it down, the Boston Globe reports. No one knows what makes it spread—and trigger 90% of cancer deaths—and a drop in deaths is due to lifestyle changes and early diagnosis, not better drugs. Yet one expert claims that progress is being made, quietly, behind closed doors. More »

  • Taxol Found Ineffective in Many Breast Cancers

    Oct 11, 07 11:09 AM CDT
    Taxol Found Ineffective in Many Breast Cancers A widely prescribed chemotherapy drug isn't effective against the kind of breast cancer it's most commonly used to treat, new research has found. While Taxol worked well for women with overactive HER-2 genes, it didn't significantly help women with the most common form of the disease in which tumors are HER-2 negative and use estrogen to grow. More »

  • 'Smart Bra' Developing as Cancer Detector

    Oct 5, 07 8:00 AM CDT
    'Smart Bra' Developing as Cancer Detector Lingerie is about to become a lifesaver. UK researchers are developing a bra that would detect breast cancer, and hope to stitch the same technology into briefs that spot prostate cancer, reports the Discovery Channel. Serving as an early-warning system, the underwear would monitor temperature changes between areas of internal tissue, often an indication of cancerous tumors. More »

The new research shows there is a need for a "paradigm shift" in treating breast cancer survivors, Nancy U. Lin and Eric P. Winer of the Dana-Farber Cancer Institute wrote in an editorial that accompanied...   ((c) patti haskins)
New studies published today found that women can dramatically reduce the risk of breast cancer reoccuring with the use of drugs known as aromatase inhibitors.   ((c) Aine D)
Texas coach Rick Barnes, wearing a pink tie, watches during the first half of a college basketball game against Iowa State, Saturday, Feb. 9, 2008, in Ames, Iowa. Many men and women basketball teams are...   (Associated Press)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (
1
 of 1)

Tags

cancer • drugs • breast cancer • cancer research • estrogen • Novartis AG


Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other Science & Health Stories

What is Newser?

2008 Codie Finalist

Face it: there's too much news. At Newser a team of editors and writers culls the most important stories from hundreds of U.S. and international sources and reduces them to a headline, picture, and two paragraphs. It's the Newser guarantee: we can take any report or column or video and pack what you need to know into 120 words or less. Newser's short-form aggregation, visual format, and unique information tools help you get more of the kind of news you want, in a quicker and more entertaining way. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »